Previous 10 | Next 10 |
home / stock / imexf / imexf news
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / August 28, 2020 / Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today reported financial results for the three months ended June 30, 2020. All amounts, unless otherwise specified, are ex...
New Video, Podcast Episode Available on Imagin Medical's Website VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / July 15, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(FRA:DPD2) ("Imagin" or the "Company") today announced that it will begin testing the i/Blue TM Imaging System using anatom...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / May 28, 2020 / Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) ("Imagin" or the "Company") today reported financial results for the three months ended March 31, 2020. All amounts, unless otherwise specified, are expre...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / May 21, 2020 / Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) ("Imagin" or the "Company") announced today that its financial results for the second fiscal quarter ended March 31, 2020, will be released after market...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / May 21, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(FRA:DPD2) ("Imagin" or the "Company") today announced that its contract design and development firm, Optel, Inc., has delivered the functional i/Blue ™ Imaging Systems that will be used...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / May 14, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(FRA:DPD2)("Imagin" or the "Company") today provided an update on the actions the Company has taken in response to the global COVID-19 pandemic. "The sudden impact of the pandemic on the global e...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / May 12, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(FRA:DPD2) ("Imagin" or the "Company") announces its support of Bladder Cancer Awareness Month. Throughout the month of May, Imagin will be undertaking a number of efforts and activities to help ...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / April 9, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(Frankfurt:DPD2)(Stuttgart:DPD2) ("Imagin" or the "Company") announces that it has received approval from the Canadian Securities Exchange to extend the term of an aggregate of 17,919,820 outstan...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / March 10, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(FRA:DPD2) ("Imagin" or the "Company") today reported on-going market research feedback on the i/Blue™ Imaging System which enables simultaneous viewing of white and blue light images dur...
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / February 27, 2020 / Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today reported financial results for the three months ended December 31, 2019. All amounts, unless otherwise specified...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET Surgical imaging for bladder cancer Imagin Medical is a surgical imaging company. They're focusing on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company’s initially focused on bladder ca...
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin PR Newswire Ponce Therapeutic's (" Ponce ") lead product, ReBea...
Imagin Medical Announces Stock Option Grants PR Newswire VANCOUVER , BC and BOSTON , April 22, 2022 /PRNewswire/ -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) ( Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today...